Anti-HIV-1 GP120 [VRC03]

AB02806-23.0-BT
ApplicationsELISA, Neutralisation/Blocking, Other Application
Product group Antibodies
ReactivityVirus
Overview
- SupplierAbsolute Antibody
- Product NameAnti-HIV-1 GP120 [VRC03]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds CD4 binding site of the HIV-1 GP120.
- Application Supplier NoteThe binding profile of this antibody towards HIV-1 GP120 was studied using ELISA and surface plasmon resonance. The original VRC03 IgG1 antibody, successfully neutralizes over 50% of current circulating HIV-1 isolates. (Mascola et al., US8637036). This antibody was reported to bind the resurfaced stabilized core 3 (RSC3) of the mutated HIV-1 envelop glycoprotein that is also capable of binding CD4. The original IgG1 version of this antibody has a binding affinity of KD = 7.31 x 10-8 M. (PMID: 20616233). VRC03 was found to potently inhibit entry into CD4+ T cells of HIV isolated from the latent viral reservoir of infected individuals whose plasma viremia was well controlled by antiretroviral therapy (ART) (PMID: 25157148).
- ApplicationsELISA, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDVRC03
- HostRabbit
- IsotypeIgG
- Protein IDP35961
- Protein NameEnvelope glycoprotein gp160
- Scientific DescriptionThis chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203